Key Points
- Myxedema coma is severe decompensated hypothyroidism; coma is not required for diagnosis.
- Treat on clinical suspicion rather than waiting for thyroid laboratory results.
- Give stress-dose glucocorticoid before or with thyroid hormone until adrenal insufficiency has been excluded.
- IV levothyroxine is the preferred initial thyroid replacement in critically ill patients.
- Use lower thyroid hormone loading doses in older adults, smaller patients, and those with coronary disease or arrhythmia.
- Hypoventilation and hypercapnia are common reasons for intubation and may be underestimated by pulse oximetry alone.
- Use passive rather than aggressive rewarming in most patients to avoid sudden vasodilation and cardiovascular collapse.
- Identify and treat the precipitant, particularly infection, medication interruption, myocardial ischemia, stroke, cold exposure, or sedatives.
Algorithm
- Recognize altered mental status plus severe hypothyroid physiology such as hypothermia, bradycardia, hypoventilation, or hyponatremia.
- Stabilize airway, breathing, circulation, glucose, and temperature; obtain ECG and continuous monitoring.
- Draw TSH, free T4, cortisol, CBC, metabolic panel, blood gas, cultures, and precipitant-directed tests without delaying treatment.
- Give IV stress-dose glucocorticoid before or with thyroid hormone.
- Administer IV levothyroxine loading dose, reduced for age, size, coronary disease, or arrhythmia, then continue daily IV replacement.
- Consider low-dose IV liothyronine only in selected severe cases with expert input.
- Treat infection and other precipitants, correct hypoglycemia and electrolytes, and provide ventilatory and hemodynamic support.
- Track mental status, temperature, respiratory function, sodium, cardiac status, and thyroid hormone levels during recovery.
Clinical Synopsis & Reasoning
Consider myxedema coma in an older or chronically hypothyroid patient with progressive lethargy, confusion, stupor, hypothermia, bradycardia, hypoventilation, hypotension, ileus, edema, or hyponatremia, especially after infection, myocardial infarction, stroke, cold exposure, sedative use, surgery, or interruption of thyroid replacement. The term is misleading because many patients are not comatose. Diagnosis is clinical and supported by a low free T4; TSH is usually markedly elevated in primary hypothyroidism but may be low or inappropriately normal in central hypothyroidism or severe nonthyroidal illness. Draw TSH, free T4, cortisol, glucose, electrolytes, CBC, cultures when infection is possible, arterial or venous blood gas when hypoventilation is suspected, and cardiac studies as indicated. Do not wait for these results before treating a highly compatible syndrome. Hypercapnia can be substantial because of reduced ventilatory drive and respiratory muscle weakness. Hyponatremia may reflect impaired free-water clearance, while hypoglycemia raises concern for concurrent adrenal insufficiency or severe systemic illness. ECG may show sinus bradycardia, low voltage, or conduction abnormalities; echocardiography can identify pericardial effusion or ventricular dysfunction when clinically relevant. Differential diagnoses include sepsis, adrenal crisis, sedative intoxication, hypothermia from exposure, stroke, uremia, hepatic encephalopathy, and other causes of coma.
Treatment Strategy & Disposition
Admit to an ICU or equivalent monitored setting. Secure the airway and ventilate early when hypercapnia, severe hypoxemia, impaired airway protection, or progressive obtundation is present. Use passive external rewarming rather than aggressive peripheral heating in most patients because vasodilation can worsen hypotension. Treat hypoglycemia, electrolyte abnormalities, infection, and the precipitating disorder. Before or at the start of thyroid hormone treatment, administer stress-dose IV glucocorticoid because adrenal insufficiency can coexist and thyroid replacement can increase cortisol requirements. The American Thyroid Association recommends IV levothyroxine with a 200 to 400 microgram loading dose, using the lower end in smaller, older, or coronary disease patients, followed by daily replacement around 1.6 micrograms/kg with the IV dose reduced to about 75 percent of the oral equivalent. Some experts add IV liothyronine when disease is severe or conversion of T4 to T3 may be impaired; if used, ATA guidance describes a 5 to 20 microgram loading dose followed by 2.5 to 10 micrograms every 8 hours, again using lower doses in older patients or those with cardiac disease. High liothyronine doses should be avoided because observational experience has linked them with harm. Give cautious IV fluid for hypotension and use vasopressors when shock persists, while recognizing that severe hypothyroidism may blunt hemodynamic response until hormone replacement takes effect.
Epidemiology / Risk Factors
- Myxedema coma is rare but carries substantial mortality.
- It occurs most often in older adults with longstanding or undertreated hypothyroidism.
- Cold weather and intercurrent infection are classic precipitants, but cardiovascular events, medications, trauma, and surgery are also important.
- Women are affected more often because primary autoimmune hypothyroidism is more common in women.
- Delayed recognition is common because symptoms overlap with sepsis, medication effects, and other causes of encephalopathy.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| TSH and free T4 | Confirms severe thyroid hormone deficiency and helps distinguish primary from central disease | Low free T4; TSH often high in primary disease | Do not delay treatment for results |
| Serum cortisol | Screens for concomitant adrenal insufficiency | Low or indeterminate values may support adrenal disease | Draw before steroids when possible but never delay steroids |
| Blood gas | Assesses hypoventilation and acid-base status | Hypercapnia and respiratory acidosis may occur | Guides ventilatory support |
| Electrolytes and glucose | Identifies hyponatremia and hypoglycemia | Low sodium and glucose are common | Correct cautiously and serially |
| ECG | Assesses bradycardia, conduction, and ischemia | Sinus bradycardia, low voltage, QT changes may occur | Continuous monitoring during hormone replacement |
| CBC, cultures, chest imaging | Searches for infection or other precipitant | Infection may occur without robust fever | Treat plausible sepsis promptly |
| Echocardiogram | Evaluates effusion and ventricular function when indicated | Pericardial effusion may be present | Drain only for tamponade physiology or another compelling indication |
Typical Dosing (Adults)
| Medication | Dose (example) | Notes |
|---|---|---|
| IV levothyroxine loading | 200 to 400 micrograms once | Use lower dose in older, small, coronary disease, or arrhythmia patients |
| IV levothyroxine maintenance | About 1.6 micrograms/kg/day oral equivalent, reduced to roughly 75 percent while IV | Transition to enteral therapy after clinical improvement |
| IV liothyronine, selected cases | 5 to 20 micrograms loading, then 2.5 to 10 micrograms every 8 hours | Optional; use lower doses with cardiac risk and avoid excessive dosing |
| Hydrocortisone | Common stress regimen 100 mg IV every 8 hours or equivalent | Begin before or with thyroid hormone until adrenal insufficiency is excluded |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Levothyroxine IV | T4 replacement providing systemic thyroid hormone substrate | Hours to days | Core therapy for myxedema coma | ATA loading 200 to 400 micrograms, lower with age or coronary disease; daily IV dose about 75 percent of oral equivalent |
| Liothyronine IV | Direct T3 replacement | Hours | Optional adjunct in selected severe cases | Avoid high doses; arrhythmia and ischemia risk |
| Hydrocortisone | Stress-dose glucocorticoid replacement | Minutes to hours | Empiric adrenal coverage until insufficiency excluded | Obtain cortisol first when feasible but do not delay |
| Dextrose | Raises serum glucose | Minutes | Hypoglycemia | Recheck glucose and prevent recurrence |
| Norepinephrine | Vasopressor support | Minutes | Persistent shock despite cautious fluids and endocrine treatment | Titrate to perfusion while treating underlying hormone deficiency |
Prognosis / Complications
- Mortality remains significant despite modern ICU care, particularly with advanced age, persistent hypothermia, bradycardia, sepsis, or multiorgan failure.
- Mental status, ventilation, sodium, and hemodynamics usually improve over days rather than immediately after thyroid hormone administration.
- Cardiac ischemia or arrhythmia can be precipitated by overly aggressive thyroid replacement, which is why dosing is individualized.
- Failure to identify infection, adrenal insufficiency, or another precipitant increases the risk of persistent instability.
- Long-term prognosis is good when the acute trigger is controlled and reliable thyroid replacement and follow-up are established.
Patient Education / Counseling
- Explain that this is a life-threatening consequence of severe thyroid hormone deficiency and usually requires intensive monitoring.
- After recovery, review exactly how levothyroxine should be taken and address barriers to adherence or absorption.
- Discuss medications and supplements that interfere with levothyroxine absorption, including iron, calcium, and some antacids, and separate administration when appropriate.
- Arrange thyroid function reassessment after the acute illness and dose stabilization.
- Caregivers should seek urgent evaluation for recurrent profound sleepiness, confusion, hypothermia, slow breathing, or inability to take thyroid medication during serious illness.
Notes
Myxedema coma should be approached as multisystem physiologic failure caused by profound thyroid hormone deficiency, not as an abnormal TSH value. Airway and ventilation, glucocorticoid coverage, thyroid hormone replacement, cautious warming, and treatment of the precipitant all matter. The correct thyroid dose is deliberately individualized because a patient with severe hypothyroidism may also have limited coronary reserve. Clinical recovery, not rapid normalization of TSH, is the immediate therapeutic endpoint.
References
- American Thyroid Association Guidelines for the Treatment of Hypothyroidism, Myxedema Coma Section — Link
Turn OB/GYN review into patient-specific decisions.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback